| 今开：2.51 | 昨收：2.46 |
| 最高：2.52 | 最低：2.43 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.4180445E7 |
免疫子制药(IMRN)02-09 19:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-011740 Act: 34 Size: 6 MB 网页链接查看全文
免疫子制药(IMRN)03-07 21:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-020599 Act: 34 Size: 102 KB 网页链接查看全文
免疫子制药(IMRN)02-13 21:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-012867 Act: 34 Size: 60 KB 网页链接查看全文
免疫子制药(IMRN)04-23 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-035096 Act: 34 Size: 17 MB 网页链接查看全文
免疫子制药(IMRN)03-05 19:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019717 Act: 34 Size: 61 KB 网页链接查看全文
免疫子制药(IMRN)02-21 21:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-015528 Act: 34 Size: 29 MB 网页链接查看全文
免疫子制药(IMRN)02-28 21:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-017754 Act: 34 Size: 2 MB 网页链接查看全文
免疫子制药(IMRN)03-14 18:55
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-022359 Act: 34 Size: 7 MB 网页链接查看全文
免疫子制药(IMRN)04-10 18:15
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-031717 Act: 34 Size: 63 KB 网页链接查看全文
免疫子制药(IMRN)04-15 20:05
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032740 Act: 34 Size: 64 KB 网页链接查看全文
格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助，这一举措是为了研究口服免疫疗法的给药方案，以供美国军队使用。Immuron是一家处于临床阶段的医疗公司，专注于一种新型特异性... 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-035096 Act: 34 Size: 17 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-032740 Act: 34 Size: 64 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-031717 Act: 34 Size: 63 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-022359 Act: 34 Size: 7 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-020599 Act: 34 Size: 102 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-019717 Act: 34 Size: 61 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-017754 Act: 34 Size: 2 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-015528 Act: 34 Size: 29 MB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-012867 Act: 34 Size: 60 KB 网页链接
$免疫子制药(IMRN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-011740 Act: 34 Size: 6 MB 网页链接